Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
- PMID: 15942625
- PMCID: PMC2361547
- DOI: 10.1038/sj.bjc.6602658
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
Abstract
Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1-1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2-2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8-4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3-17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity.
Comment in
-
Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?Br J Cancer. 2005 Sep 19;93(6):730-2; author reply 732. doi: 10.1038/sj.bjc.6602786. Br J Cancer. 2005. PMID: 16222317 Free PMC article. No abstract available.
Similar articles
-
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.J Natl Cancer Inst. 2001 Jan 17;93(2):121-7. doi: 10.1093/jnci/93.2.121. J Natl Cancer Inst. 2001. PMID: 11208881
-
Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?Br J Cancer. 2005 Sep 19;93(6):730-2; author reply 732. doi: 10.1038/sj.bjc.6602786. Br J Cancer. 2005. PMID: 16222317 Free PMC article. No abstract available.
-
Cancer risks and mortality in heterozygous ATM mutation carriers.J Natl Cancer Inst. 2005 Jun 1;97(11):813-22. doi: 10.1093/jnci/dji141. J Natl Cancer Inst. 2005. PMID: 15928302
-
The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.Cancer Lett. 2005 Sep 28;227(2):105-14. doi: 10.1016/j.canlet.2004.12.001. Epub 2005 Jan 8. Cancer Lett. 2005. PMID: 16112413 Review.
-
ATM and breast cancer susceptibility.Oncogene. 2006 Sep 25;25(43):5906-11. doi: 10.1038/sj.onc.1209873. Oncogene. 2006. PMID: 16998505 Review.
Cited by
-
Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Cancer. 2015 Mar 1;121(5):648-63. doi: 10.1002/cncr.29096. Epub 2014 Oct 29. Cancer. 2015. PMID: 25355167 Free PMC article. Review.
-
Bayesian meta-analysis of penetrance for cancer risk.Biometrics. 2024 Mar 27;80(2):ujae038. doi: 10.1093/biomtc/ujae038. Biometrics. 2024. PMID: 38819308 Free PMC article.
-
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. doi: 10.1093/jnci/djq055. Epub 2010 Mar 19. J Natl Cancer Inst. 2010. PMID: 20305132 Free PMC article.
-
Adjusting for Ascertainment Bias in Meta-Analysis of Penetrance for Cancer Risk.Stat Med. 2025 Feb 10;44(3-4):e10323. doi: 10.1002/sim.10323. Stat Med. 2025. PMID: 39865362
-
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence.Radiat Oncol. 2007 Jul 10;2:25. doi: 10.1186/1748-717X-2-25. Radiat Oncol. 2007. PMID: 17623063 Free PMC article.
References
-
- Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130–134 - PubMed
-
- Bailar JC, Ederer F (1964) Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 20: 639–643
-
- Bernstein JL, Teraoka S, Haile RW, Borresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P (2003) WECARE Study Collaborative Group. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat 21: 542–550 - PubMed
-
- Bianchi DW (2000) Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 91: 22–28 - PubMed
-
- Cha D, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson KL (2003) Cervical cancer and michrochimerism. Obstet Gynecol 102: 774–781 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous